Literature DB >> 21131540

Metformin during pregnancy in polycystic ovary syndrome: another vitamin bites the dust.

Richard S Legro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21131540      PMCID： PMC2999976          DOI： 10.1210/jc.2010-2301

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

1.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

2.  Placental passage of metformin in women with polycystic ovary syndrome.

Authors:  Eszter Vanky; Kolbjørn Zahlsen; Olav Spigset; Sven Magnus Carlsen
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

3.  Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.

Authors:  Stefano Palomba; Francesco Orio; Angela Falbo; Francesco Manguso; Tiziana Russo; Teresa Cascella; Achille Tolino; Enrico Carmina; Annamaria Colao; Fulvio Zullo
Journal:  J Clin Endocrinol Metab       Date:  2005-04-19       Impact factor: 5.958

Review 4.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Thomas Tang; Jonathan M Lord; Robert J Norman; Ephia Yasmin; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

Authors:  J E Nestler; D J Jakubowicz
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

Review 6.  Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Stefano Palomba; Angela Falbo; Francesco Orio; Fulvio Zullo
Journal:  Fertil Steril       Date:  2008-10-19       Impact factor: 7.329

7.  Metformin versus insulin for the treatment of gestational diabetes.

Authors:  Janet A Rowan; William M Hague; Wanzhen Gao; Malcolm R Battin; M Peter Moore
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

8.  Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study.

Authors:  K J Fougner; E Vanky; S M Carlsen
Journal:  Scand J Clin Lab Invest       Date:  2008       Impact factor: 1.713

9.  Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

Authors:  J E Nestler; D J Jakubowicz; W S Evans; R Pasquali
Journal:  N Engl J Med       Date:  1998-06-25       Impact factor: 91.245

Review 10.  Antioxidants for preventing pre-eclampsia.

Authors:  A Rumbold; L Duley; C A Crowther; R R Haslam
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  4 in total

Review 1.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

2.  Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome.

Authors:  Ugochi C Okoroafor; Emily S Jungheim
Journal:  Patient Prefer Adherence       Date:  2012-05-24       Impact factor: 2.711

3.  Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.

Authors:  Henriikka Salomäki; Laura H Vähätalo; Kirsti Laurila; Norma T Jäppinen; Anna-Maija Penttinen; Liisa Ailanen; Juan Ilyasizadeh; Ullamari Pesonen; Markku Koulu
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

4.  HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Sven Magnus Carlsen
Journal:  BMC Endocr Disord       Date:  2015-08-06       Impact factor: 2.763
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.